O'Dell Group, LLC Dexcom Inc Transaction History

O'Dell Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$75.49 - $124.16 $32,989 - $54,257	437 New	437 $54,000
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $46,899 - $54,618	417 New	417 $53,000
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $21,144 - $41,328	311 Added 208.72%	460 $34,000
Q1 2022 May 05, 2022	BUY	$94.08 - $130.2 $14,017 - $19,399	149 New	149 $76,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of O'Dell Group, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Dell Group, LLC with notifications on news.